GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q1 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $17,155,000 | -19.5% | 445,468 | -9.8% | 0.02% | -23.1% |
Q3 2016 | $21,307,000 | -3.0% | 494,017 | -2.5% | 0.03% | -7.1% |
Q2 2016 | $21,962,000 | +20.5% | 506,743 | +12.7% | 0.03% | +16.7% |
Q1 2016 | $18,229,000 | +27.5% | 449,537 | +26.9% | 0.02% | +33.3% |
Q4 2015 | $14,295,000 | +0.6% | 354,270 | -4.1% | 0.02% | -5.3% |
Q3 2015 | $14,206,000 | -39.9% | 369,469 | -34.9% | 0.02% | -34.5% |
Q2 2015 | $23,652,000 | -3.5% | 567,870 | +6.9% | 0.03% | -9.4% |
Q1 2015 | $24,516,000 | +37.7% | 531,214 | +27.5% | 0.03% | +33.3% |
Q4 2014 | $17,809,000 | -12.2% | 416,694 | -5.5% | 0.02% | -14.3% |
Q3 2014 | $20,280,000 | -44.7% | 441,165 | -35.7% | 0.03% | -42.9% |
Q2 2014 | $36,692,000 | +19.8% | 686,085 | +19.6% | 0.05% | +11.4% |
Q1 2014 | $30,638,000 | +13.4% | 573,424 | +13.3% | 0.04% | +10.0% |
Q4 2013 | $27,020,000 | +99.4% | 506,094 | +87.4% | 0.04% | +81.8% |
Q3 2013 | $13,551,000 | -13.3% | 270,109 | -13.6% | 0.02% | -21.4% |
Q2 2013 | $15,622,000 | – | 312,629 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |